Literature DB >> 20153004

Glycosylphosphatidylinositol-specific phospholipase D improves glucose tolerance.

Nandita S Raikwar1, Rosario F Bowen-Deeg, X Sean Du, Martin G Low, Mark A Deeg.   

Abstract

Insulin regulation of energy metabolism is complex and involves numerous signaling cascades. Insulin has been suggested to stimulate a phospholipase that cleaves glycosylphosphatidylinositols resulting in the generation of an inositol glycan that serves as an insulin mediator. To determine if glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD) may play a role in glucose metabolism, we examined the effect of overexpressing GPI-PLD using adenovirus-mediated gene transfer in C57BL/6 mice. Overexpressing GPI-PLD was associated with a decrease in fasting glucose as well as an improvement in glucose tolerance as determined by an intraperitoneal glucose tolerance test. This effect to improve glucose tolerance does not result from an increase in insulin sensitivity, as overexpressing GPI-PLD does not alter the response to insulin. In contrast, the insulin response during the glucose tolerance test in GPI-PLD-overexpressing mice was increased. Overexpressing GPI-PLD in an insulinoma cell line enhanced glucose-stimulated insulin secretion, suggesting that enhanced insulin secretion in vivo may have contributed to the improved glucose tolerance. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153004     DOI: 10.1016/j.metabol.2008.11.021

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

1.  Discovery of a novel circulating biomarker in patients with abdominal aortic aneurysm: a pilot study using a proteomic approach.

Authors:  Jonas Wallinder; Jörgen Bergström; Anders E Henriksson
Journal:  Clin Transl Sci       Date:  2012-01-10       Impact factor: 4.689

2.  Plasma glycosylphosphatidylinositol phospholipase D (GPI-PLD) and abdominal aortic aneurysm.

Authors:  Markus Lindqvist; Jonas Wallinder; Jörgen Bergström; Anders E Henriksson
Journal:  Int J Clin Exp Med       Date:  2012-08-20

3.  Structure-function relationships of HDL in diabetes and coronary heart disease.

Authors:  Mathias Cardner; Mustafa Yalcinkaya; Sandra Goetze; Edlira Luca; Miroslav Balaz; Monika Hunjadi; Johannes Hartung; Andrej Shemet; Nicolle Kränkel; Silvija Radosavljevic; Michaela Keel; Alaa Othman; Gergely Karsai; Thorsten Hornemann; Manfred Claassen; Gerhard Liebisch; Erick Carreira; Andreas Ritsch; Ulf Landmesser; Jan Krützfeldt; Christian Wolfrum; Bernd Wollscheid; Niko Beerenwinkel; Lucia Rohrer; Arnold von Eckardstein
Journal:  JCI Insight       Date:  2020-01-16

4.  Serum glypican4 and glycosylphosphatidylinositol-specific phospholipase D levels are associated with adipose tissue insulin resistance in obese subjects with different glucose metabolism status.

Authors:  K Zhang; H Zhu; L Wang; H Yang; H Pan; F Gong
Journal:  J Endocrinol Invest       Date:  2020-08-20       Impact factor: 4.256

5.  Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine.

Authors:  Siegfried Ussar; Olivier Bezy; Matthias Blüher; C Ronald Kahn
Journal:  Diabetes       Date:  2012-06-29       Impact factor: 9.461

6.  Endurance exercise training restores diabetes-induced alteration in circulating Glycosylphosphatidylinositol-specific phospholipase D levels in rats.

Authors:  Farzad Abdolmaleki; Ali Heidarianpour
Journal:  Diabetol Metab Syndr       Date:  2020-05-19       Impact factor: 3.320

7.  Interaction of Full-Length Glycosylphosphatidylinositol-Anchored Proteins with Serum Proteins and Their Translocation to Cells In Vitro Depend on the (Pre-)Diabetic State in Rats and Humans.

Authors:  Günter A Müller; Andreas Lechner; Matthias H Tschöp; Timo D Müller
Journal:  Biomedicines       Date:  2021-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.